PM00104 (Zalypsis®): A Marine Derived Alkylating Agent

PM00104 (Zalypsis®): A Marine Derived Alkylating Agent

PM00104 (Zalypsis®) is a synthethic tetrahydroisoquinolone alkaloid, which is structurally similar to many marine organisms. The compound has been proposed as a potential chemotherapeutic agent in the treatment of solid human tumors and hematological malignancies. PM00104 is a DNA binding agent, c...

Full description

Bibliographic Details
Main Authors: Bradley J. Petek, Robin L. Jones
Format: Article
Language:English
Published: MDPI AG 2014-08-01
Series:Molecules
Subjects:
PM00104
Zalypsis
alkaloid
chemotherapy
cancer therapy
Online Access:http://www.mdpi.com/1420-3049/19/8/12328
Description
Summary:PM00104 (Zalypsis®) is a synthethic tetrahydroisoquinolone alkaloid, which is structurally similar to many marine organisms. The compound has been proposed as a potential chemotherapeutic agent in the treatment of solid human tumors and hematological malignancies. PM00104 is a DNA binding agent, causing inhibition of the cell cycle and transcription, which can lead to double stranded DNA breaks. After rigorous pre-clinical testing, the drug has been evaluated in a number of phase II clinical trials. This manuscript provides a review of current trials and appraises the efficacy of PM00104 as a future cancer treatment.
ISSN:1420-3049

Similar Items